Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: alpha-CD

January 23, 2025 CD as API / Food / Pharma applications

 Alpha-cyclodextrin supplementation improves endurance exercise  performance and reduces  post exercise fatigue  in human males.  a randomised, double blind  placebo controlled paralell group study 

It huas been recently reported that αCD supplementation for eight weeks in nonathlete men improved the 10 km biking time compared

Continue reading

January 13, 2025 CD as API / Drug delivery / Pharma applications

Winners of 2024 Lasker-DeBakey Clinical Medical Research Award for their pioneering works on GLP-1-based therapy for obesity

This year Lasker-De Bakey Clinical Medical Research Award honoured three scientists for their discovery and development of glucagon-like peptide-1 (GLP-1)-

Continue reading

December 16, 2024 Food / Non-pharma applications / Uncategorized

Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in mice

Alpha-cyclodextrin (α-CD) is a non-absorbable and soluble fiber that causes weight loss. In this work it was studied whether this

Continue reading

December 12, 2024 CD as API / Pharma applications

Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease

This noticable mini review was published in the last year but worth not to overlook as it is in line

Continue reading

November 11, 2024 CD as API / Pharma applications

The role of gut in Parkinson’s disease

The role of gut in development of Parkinson’s disease has been long suspected as constipation appears years before the typical

Continue reading

November 8, 2024 Food / Non-pharma applications

CD-induced Modulation of Immunoglobulin A Reactivity to Gut Bacteria Contributes to Alterations in the Bacterial Community

Immunoglobulin A (IgA) is a major gut antibody that coats commensal gut bacteria and contributes to shaping a stable gut

Continue reading

August 29, 2024 CD derivatives

New methods of modification of α-cyclodextrin

While being some of the oldest supramolecular hosts, cyclodextrins remain very popular as molecular binders in materials, devices, artificial enzymes

Continue reading

July 8, 2024 CD as API / Drug delivery / Pharma applications

Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

Aging is a complex and time-dependent decline in physiological function that affects most organisms, leading to increased risk of age-related

Continue reading

June 5, 2024 Food

Alpha-Cyclodextrin Containing Barista Oat Drink

Pascual, a Spanish dairy company founded in 1969 by Tomás Pascual set up a brand (Vivesoy) in 2002, a time

Continue reading

January 22, 2024 CD as API / Pharma applications

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D)

Dyslipidemia is common in individuals with T2D and clinical studies show cholesterol and lipid management reduce diabetic retinopathy (DR) progression.

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 Next Posts»

Recent Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives
  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (133)
  • Events (233)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,173)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
  • "Advances in Functional Materials" International Conference, 2021
  • Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease
  • Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...